A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.

Clinical trial NCT07037394 · COMPLETED

Trial details

NCT number: NCT07037394
Sponsor: Qurratul Ain Jamil
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Overt Hepatic Encephalopathy

Start date: 2024-12-02
Primary completion: 2025-04-21
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.